A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 1, 2001, Pages 280-287

  Boyle Vavra, S ^a   Labischinski, H ^a   Ebert, C C ^a   Ehlert, K ^a   Daum, R S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; GLYCOPEPTIDE; PEPTIDOGLYCAN; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BACTERIUM ISOLATION; DATA ANALYSIS; HYBRIDIZATION; JAPAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; PEPTIDOGLYCAN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0035174677     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.1.280-287.2001     Document Type: Article

References (23)

1. The structure and mode of action of glycopeptide antibiotics of the vancomycin group
2. Reversion of glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates
3. Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999
4. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997
5. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, Sept. 1997
6. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: Isolation and purification of a constitutively produced protein associated with decreased susceptibility
7. Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain: The role of penicillin binding protein 2A
8. Peptidoglycan composition of vancomycin resistant enterococci
9. Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf area
10. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50
11. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50
12. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
13. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
14. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus
15. Vancomycin-resistant enterococcal infections
16. Improved high-performance liquid chromatographic separation of peptidoglycan isolated from various Staphylococcus aureus strains for mass spectrometric characterization
17. Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia
18. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
19. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus
20. Emergence of vancomycin resistance in Staphylococcus aureus
21. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus
22. Glutamine synthetase and heteroresistance in methicillin-resistant Staphylococcus aureus